Pulse Wave Velocity as a Marker of Vascular Dysfunction and Its Correlation with Cardiac Disease in Children with End-Stage Renal Disease (ESRD).
Cristina FilipCatalin Gabriel CirstoveanuMihaela BizubacCamelia Elena BergheaAndrei CăpitănescuMihaela BălgrădeanCarmen PavelescuAlin NicolescuMarcela Daniela IonescuPublished in: Diagnostics (Basel, Switzerland) (2021)
One of the main markers of arterial stiffness is pulse wave velocity (PWV). This parameter is well studied as a marker for end-organ damage in the adult population, being considered a strong predictor of major cardiovascular events. This study assessed PWV in children with chronic kidney disease (CKD) as a marker of cardiovascular risk. We conducted a prospective observational single-center cohort study of 42 consecutively pediatric patients (9-18 years old) with terminal CKD and dialysis, at the Hemodialysis Department of the "M. S. Curie" Hospital, Bucharest. We measured PWV by echocardiography in the ascending aorta (AscAo) and the descending aorta (DescAo), and we correlated them with left ventricular hypertrophy (LVH). Fifteen patients (35.7%) presented vascular dysfunction defined as PWV above the 95th percentile of normal values in the AscAo and/or DescAo. Cardiac disease (LVH/LV remodeling) was discovered in 32 patients (76.2%). All patients with vascular damage also had cardiac disease. Cardiac damage was already present in all patients with vascular disease, and the DescAo is more frequently affected than the AscAo (86.6% vs. 46.9%). Elevated PWV could represent an important parameter for identifying children with CKD and high cardiovascular risk.
Keyphrases
- end stage renal disease
- chronic kidney disease
- left ventricular
- peritoneal dialysis
- cardiovascular events
- oxidative stress
- young adults
- blood pressure
- coronary artery disease
- heart failure
- cardiovascular disease
- aortic valve
- type diabetes
- computed tomography
- acute myocardial infarction
- pulmonary artery
- coronary artery
- mitral valve
- cardiac resynchronization therapy
- blood flow
- ejection fraction
- pulmonary hypertension
- emergency department
- tertiary care
- transcatheter aortic valve replacement
- left atrial
- acute coronary syndrome
- drug induced
- prognostic factors
- patient reported outcomes